Prakt. lékáren. 2015; 11(1): 19-22

Pharmaceutical care possibilities in patients with neuropathic pain

Jana Vinšová1, Mira Hojdarová2
1 Oddělní klinické farmacie, Ústřední vojenská nemocnice &ndash, Vojenská fakultní nemocnice Praha

Despite a number of consensual guidelines the management of neuropathic pain remains a difficult and not always successful mission.

The aim of the article is to provide an overview of neuropathic pain pharmacotherapy with the emphasis on evidence based medicine

and also to specify possibilities of pharmaceutical care of these patients.

Keywords: neuropathic pain, pharmacotherapy, pharmaceutical care

Published: February 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vinšová J, Hojdarová M. Pharmaceutical care possibilities in patients with neuropathic pain. Praktické lékárenství. 2015;11(1):19-22.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Augustine GJ, a další. Neuroscience 3rd edition. Sunderland: Sinauer Associates, Inc., 2004: 209-228. ISBN 0-87893-725-0.
    2. Treede RD, a další. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008; 70(18): 1630-1635. Go to original source... Go to PubMed...
    3. Ansari Z. Int J Basic Clin Pharmacol. 2013; 2(3): 229-236. Go to original source...
    4. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. Neuromuskulární sekce České Neurologické Společnosti. [Online] [Citace: 21. Prosinec 2014.] http://www.neuromuskularni-sekce.cz/index.php?pg=odborne-materialy-doporuceny-postup-pro-lecbu-neuropaticke-bolesti.
    5. Ambler Z. Neuropatická bolest - hlavní příčiny a terapie. Postgraduální medicína. 2011; 13(6): 598-605.
    6. Torrance N, a další. Neuropathic pain in the community: More under-treated than refractory? Pain. 2013; 154(5): 690-699. Go to original source... Go to PubMed...
    7. Attal N, a další. EFNS guidelines on pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010; 17: 1113-1123. Go to original source... Go to PubMed...
    8. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009; 122: 22-32. Go to original source... Go to PubMed...
    9. Červený R, a další. Geriatrie. Novelizace 2014. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře. ISBN 978-80-86998-69-5.
    10. SPC Effectin. www.sukl.cz. [Online] [Citace: 29. 12 2014.]
    11. Bockbrader HN, a další. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010; 49: 661-669. Go to original source... Go to PubMed...
    12. SPC Lyrica. www.sukl.cz. [Online] [Citace: 29. 12 2014.]
    13. SPC Neurontin. www.sukl.cz. [Online] [Citace: 29. 12 2014.]
    14. SPC Tegretol. www.sukl.cz. [Online] [Citace: 29. 12 2014.]
    15. Gronseth G, a další. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008; 71: 1183-1190. Go to original source... Go to PubMed...
    16. Moulin D, a další. Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society. Pain Res Manag. 2014; 19(6): 328-335. Go to original source... Go to PubMed...
    17. Attal N, a další. EFNS guidelines on pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010; 17: 1113-1123. Go to original source... Go to PubMed...
    18. Sommer C, a další. Opioids in chronic neuropathic pain: A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration. Springer Link. [Online] Nov 2014. [Citace: 22. Dec 2014.] http://link.springer.com/article/10.1007%2Fs00482-014-1455-x.
    19. Haanpää M, a další. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011; 152(1): 14-27. Go to original source... Go to PubMed...
    20. McNicol E D, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. [CD006146] 2013. 8. Go to original source... Go to PubMed...
    21. Smith HS, Kara DK, Argoff CE. Management of neuropathic pain: current insights and future perspectives. US Neurology. 2012; 8(1): 57-61. Go to original source...
    22. Hakl M, Ševčík P. Opioidní analgetika v léčbě chronické bolesti. Remedia. 2012; 22(6): 408-411.
    23. Ansari Z. Evidence-based pharmacological management of. Int J Basic Clin Pharmacol. 2013; 2(3): 229-236. Go to original source...
    24. Oxycodone. Medscape. [Online] [Citace: 23. Prosinec 2014.] http://reference.medscape.com/drug/roxicodone-oxycontin-oxycodone-343321#10.
    25. Smith H, Bruckenthal P. Implications of Opioid Analgesia for Medically Complicated Patients. Drugs Aging. 2010; 27(5): 417-433. Go to original source... Go to PubMed...
    26. Smith HS. Opioids and Neuropathic Pain. Pain Physician. [Online] Červenec 2012. [Citace: 23. Prosinec 2014.] http://painphysicianjournal.com/2012/july/2012;15;ES93-ES110.pdf. Go to original source...
    27. SPC Versatis. www.sukl.cz. [Online] [Citace: 29. 12 2014.]
    28. SPC Qutenza. www.sukl.cz. [Online] [Citace: 29. 12 2014.]
    29. Dworkin RH, a další. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007; 132(3): 237-251. Go to original source... Go to PubMed...
    30. Raudenská J, Javůrková A. Multidisciplinární léčba chronické nenádorové bolesti. Bolest. 2010; 13(3): 117-123.
    31. Gregorová J. Metodika I - práce na oddělení klinické farmacie - optimalizace farmakoterapie pacienta. Praha : AMCA, 2013. ISBN 978-80-905449-1-8.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.